___

• Tang WK, Ungvari GS. Continuation and maintenance electroconvulsive therapy: a selective review of the literature. Hong Kong J Psychiatry 1999; 9:6-12.
• Andrade C, Kurinji S. Continuation and maintenance ECT: A review of recent research. J ECT 2002; 18:149-158.
• Prudic J, Olfson M, Sackeim HA. Electro-convulsive therapy practices in the community. Psychol Med 2001; 31:929–934.
• American Psychiatric Association. The Practice of ECT: Recommendations for Practice, Training, and Privileging. Task Force Report on ECT. Washington, DC, American Psychiatric Press, 1990.
• American Psychiatric Association Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd ed. Washington, DC, American Psychiatric Association, 2001.
• Royal College of Psychiatrists’ Special Committee on ECT. The ECT Handbook, 2nd ed. London, UK, The Royal College of Psychiatrists, 2005.
• National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy (Technology Appraisal 59). London, UK, National Institute for Clinical Excellence, 2003.
• Steffens DC, Krystal AD, Sibert TE, Moore SD, Weiner RD. Cost effectiveness of maintenance ECT. Convuls Ther 1995; 11:283-284.
• Bonds C, Frye MA, Coudreaut MF, Cunningham M, Spearing M, McGuire M et al. Cost reduction with maintenance ECT in refractory bipolar disorder. J ECT 1998; 14:36-41.
• McDonald WM, Phillips VL, Figiel GS, Marsteller FA, Simpson CD, Bailey MC. Cost- effective maintenance treatment of resistant geriatric depression. Psychiatr Ann 1998; 28:47-52.
• Aziz M, Mehringer AM, Mozurkewich E, Razik GN. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electro- convulsive therapy: results from a decision analytic model. Can J Psychiatry 2005; 50:389-397.
• Moss L E, Vaidya N A. Electroconvulsive therapy as an alternative treatment for obese patients with mood disorders. J ECT 2006; 22:223-225.
• Wijkstra J, Nolen WA, Algra A, van Vliet IM, Kahn RS. Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand 2000: 102:454-460.
• Shimizu E, Imai M, Fujisaki M, Shinoda N, Handa S, Watanabe H et al. Maintenance ECT for treatment resistant disorganized schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:571-573.
• Consoli A, Boulicot V, Cornic F, Fossati P, Barbeau M, Cohen D. Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia. Eur Child Adolesc Psychiatry 2009; 18:250-254.
• Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord 2001; 63:1- 15.
• Jarvis MR, Zorumski CF, Goewert AJ, Rasmussen KG. Maintenance electroconvulsive therapy and seizure duration. Convuls Ther 1993; 9:8-13.
• Francis A, Fochtmann L. Sustained downregulation of cortical adrenergic receptor density with maintenance electroconvulsive stimulation. Convuls Ther 1993; 9:185- 191.
• Fochtmann LJ. Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 1994; 30:321-444.
• Andrade C, Sudha S. Electroconvulsive therapy and the alpha-2 noradrenergic receptor: implications of treatment schedule effects. J ECT 2000; 16:268-278.
• Seethalakashmi R, Parkar S R, Nair N, Pandit A G. Increased Thalamostriatal- Mesiotemporal Glucose Uptake with symptom remission in schizophrenia. J ECT 2006; 22:74-75.
• Tomruk NB, Oral T. Elektrokonvulsif tedavinin klinik kullanımı: Bir gözden geçirme. Anadolu Psikiyatri Dergisi 2007; 8:302-309.
• Frederikse M, Petrides G, Kellner C. Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence Report. J ECT 2006; 22:13-17.
• Chanpattana W, Andrade C. ECT for treatment-resistant schizophrenia: A response from the Far East to the UK. NICE Report. J ECT 2006; 22:4-12.
• Tielkes C E M, Comijs H C, Verwijk E, Stek M L. The effects of ECT on cognitive functioning in the elderly: a review. Int J Geriatr Psychiatry 2008; 23:789-795.
• Wahlund B, von Rosen D. ECT of major depressed patients in relation to biological and clinical variables: a brief overview. Neuropsychopharmacology. 2003; 28(Suppl 1):S21-S26.
• Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991; 14:803-843.
• Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 2003; 160:577-579.
• Mervaala E, Kononen M, Fohr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT et al. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 2001; 66:47-58.
• Palmio J, Huuhka M, Saransaari P, Oja SS, Peltola J, Leinonen E et al. Changes in plasma amino acids after electroconvulsive therapy of depressed patients. Psychiatry Res 2005; 137:183-190.
• Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non- antidepressant drug treatments. Brain Res 2008; 1211:37-43. 32. Eker C, Ovali GY, Ozan E, Eker OD, Kitis O,
• Coburn K et al. Prog
• Neuropsychopharmacol Biol Psychiatry 2008; 32:1628-1632.
• Grunhaus L, Zelnik T, Albala AA, Rabin D, Haskett RF, Zis AP et al. Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. J Affect Disord 1987; 13:233-240.
• Maayan R, Yagorowski Y, Grupper D, Weiss M, Shtaif B, Kaoud MA et al. Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients. Biol Psychiatry 2000; 48:693-701.
• Baghai TC, Möller HJ. Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci 2008; 10:105-117.
• Consensus Devolopment Panel. Mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry 1985; 142:469-476.
• Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL et al. A double- blind, placebo controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder: Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841-850.
• Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the ‘kindling‘ hypothesis. Am J Psychiatry 2000; 157:1243-1251.
• Kendler KS, Thornton LM, Gardner CO. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am J Psychiatry 2001;158:582–586.
• Vanelle J-M, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther 1994; 10:195-205.
• Gagne GG, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared with long-term antidepressants alone in depressed patients. Am J Psychiatry 2000; 157:1960-1965.
• Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschutz L. Outpatient electroconvulsive therapy: efficacy and safety. Convuls Ther 1990; 6:231-238.
• Dubin WR, Jaffe R, Roemer R, Siegel L, Shoyer B, Venditti ML. The efficacy and safety of maintenance ECT in geriatric patients. J Am Geriatr Soc 1992; 40:706-709.
• Puri BK, Langa A, Coleman RM, Singh I. The clinical efficacy of maintenance electroconvulsive therapy in a patient with a mild mental handicap. Br J Psychiatry 1992; 161:707-709.
• Petrides G, Dhossche D, Fink M, Francis A. Continuation ECT: Relapse prevention in affective disorders. Convuls Ther 1994; 10:189-194.
• Fox HA. Extended continuation and maintenance ECT for long-lasting episodes of major depression. J ECT 2001; 17:60-64.
• Kramer BA. A naturalistic review of maintenance ECT at a university setting. J ECT 1999; 15:262-269.
• Swoboda E, Conca A, Konig P, Waanders R, Hansen M. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 2001; 43:23-28.
• Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT 2000; 16:204-207.
• Gupta S, Tobiansky R, Bassett P, Warner J. Efficacy of maintenance electroconvulsive therapy in recurrent depression: A naturalistic study. J ECT 2008; 24:191-194.
• Clarke TB, Coffey CE, Hoffman GW, Weiner RD. Continuation therapy for depression using outpatient electroconvulsive therapy. Convuls Ther 1989; 5:330-337.
• McDonald WM, Thompson TR, Okun L, Beyer K, Holtzheimer PE, Woodard JL. Post- ECT continuation and maintenance. J ECT 2005; 21:54-55.
• Russell JC, Rasmussen KG, O'Connor MK, Copeman CA, Ryan DA, Rummans TA. Long-term maintenance ECT: A retrospective review of efficacy and cognitive outcome. J ECT. 2003; 19:4-9.
• Monroe RE. Maintenance electroconvulsive therapy. Psychiatr Clin North Am 1991; 14:947-960.
• Bozkurt A, Karlidere T, Isintas M, Ozmenler NK, Ozsahin A, Yanarates O. Acute and maintenance electroconvulsive therapy for treatment of psychotic depression in a pregnant patient. J ECT 2007; 23:185-187.
• Jaffe RL, Rives W, Dubin WR, Roemer RA, Siegel L. Problems in maintenance ECT in bipolar disorder: Replacement by lithium and anticonvulsants. Convuls Ther 1991; 7:288-294.
• Schwarz T, Loewenstein J, Isenberg K E. Maintenance ECT: Indications and outcome. Convuls Ther 1995; 11:14-23.
• Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression. Arch Gen Psychiatry 2006; 63:1337-1344.
• Srinivasan TN, Suresh TR, Jayaram V. Issues in the use of maintenance electroconvulsive therapy. Indian J Psychiatry 1995; 37:139-142.
• Rasmussen KG. Clinical applications of recent research of ECT. Bull Menninger Clin 2003; 67:18-31.
• Kellner CH, Burns CM, Bernstein HJ, Monroe RR. Electrode placement in maintenance electroconvulsive therapy. Convuls Ther 1991; 7:61-62.
• Navarro V, Gasto´ C, Torres X Masana G, Penadés R, Guarch J et al. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: A two-year randomized study. Am J Geriatr Psychiatry 2008; 16:498-505.
• Fink M. Efficacy of ECT. Lancet. 1979; 2:1303-1304.
• Kales HC, Dequardo JR, Tandon R. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23:547-556.
• Havaki-Kontaxaki BJ, Ferentinos PP, Kontaxakis VP, Paplos KG, Soldatos CR. Concurrent administration of clozapine and electroconvulsive therapy in clozapine- resistant schizophrenia. Clin Neuropharmacol 2006; 29:52-56.
• Chanpattana W, Chakrabhand MLS, Sackeim HA, Kitaroonchai W, Kongsakon R, Techakasem P et al. Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT 1999; 15:129-139.
• Chanpattana W, Chakrabhand ML. Factors influencing treatment frequency of continuation ECT in schizophrenia. J ECT 2001; 17:190-194.
• Chanpattana W. Maintenance ECT in mentally retarded, treatment resistant schizophrenic patients. J ECT 1999;15:150-153.
• Thuppal M, Fink M. Electroconvulsive therapy and mental retardation. J ECT 1999; 15:140-149.
• Casey DA, Davis MH. Obsessive-compulsive disorder responsive to electroconvulsive therapy in an elderly woman. South Med J 1994; 87:862-864.
• Husain MM, Lewis SF, Thornton WL. Maintenance ECT for refractory obsessive- compulsive disorder. Am J Psychiatry 1993; 150:1899-1900.
• Shulman R. Maintenance ECT in the treatment of PD. Geriatrics 2003; 58:43-45.
• Gandaghar BN, Kapur RL. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double-blind study. Br J Psychiatry 1982; 141:367-371.
• Sackeim HA, Portnoy S, Neeley P, Steif BL, Decina P, Malitz S. Cognitive consequences of low-dosage electroconvulsive therapy. Ann NY Acad Sci 1986; 462:326-340.
• Hill GE, Wong KC, Hodges MR. Lithium carbonate and neuromuscular blocking agents. Anesthesiology 1977; 46:122-126.
• Reimherr FW, Hodges MR, Hill GE, Wong KC. Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry 1977; 134:205-206.
• Krystal AD, Coffey CE. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 1997; 9:283-292.
• Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment- resistant patient. Psychiatr Clin N Am 1991; 14:905-923.
• Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004; 65:485-491.
• Ghaziuddin N, Laughrin D, Giordani B. Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 2000; 10:269-276.
• Datto CJ, Levy S, Miller DS, Katz IR. Impact of maintenance ECT on concentration and memory. J ECT 2001; 17:170-174.
• Grunhaus L, Pande AC, Haskett RF. Full and abbreviated courses of maintenance electroconvulsive therapy. Convuls Ther 1990; 6:130-138.
• Rami-Gonzalez L, Salamero M, Boget T, Catalan R, Ferrer J, Bernardo M. Pattern of cognitive dysfunction in depressive patients during maintenance electroconvulsive therapy. Psychol Med 2003; 33:345-350.
• Abraham G, Milev R, Delva N, Zaheer J. Clinical outcome and memory function with maintenance electroconvulsive therapy: A retrospective study. J ECT 2006; 22:43-45.
• Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007; 32:244-254.
• Sackeim HA. The convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clin Neurosci 2004; 4:39-57.